UK Markets open in 4 hrs 23 mins
NIKKEI 225
29,363.22-78.08(-0.27%)HANG SENG
28,548.42-90.11(-0.31%)CRUDE OIL
72.70+0.58(+0.80%)
Neurocrine Biosciences, Inc. (0K6R.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
100.55+6.11 (+6.47%)
At close: 2:52PM BST
| Previous close | 94.44 |
| Open | 100.55 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 100.55 - 100.55 |
| 52-week range | 100.55 - 100.55 |
| Volume | 50 |
| Avg. volume | N/A |
| Market cap | 9.895B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 24.17 |
| EPS (TTM) | 4.16 |
| Earnings date | 02 Aug 2021 - 06 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Neurocrine Biosciences (NASDAQ:NBIX) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- Motley Fool
Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript
NBIX earnings call for the period ending March 31, 2021.
- Zacks
Neurocrine Biosciences (NBIX) Q1 Earnings and Revenues Miss Estimates
Neurocrine (NBIX) delivered earnings and revenue surprises of -29.79% and -4.52%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
© 2021 Verizon Media. All rights reserved.
